Log in

ASX:COHCochlear Stock Price, Forecast & News

A$182.02
-7.98 (-4.20 %)
(As of 04/5/2020 02:44 PM ET)
Add
Compare
Today's Range
A$178.29
Now: A$182.02
A$195.27
50-Day Range
A$157.81
MA: A$205.05
A$247.90
52-Week Range
A$154.60
Now: A$182.02
A$254.40
Volume445,282 shs
Average Volume194,422 shs
Market Capitalization$10.53 billion
P/E Ratio34.38
Dividend Yield1.94%
BetaN/A
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. It also provides Cochlear true wireless devices comprising mini microphones, phone clips, and TV streamers; and Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses. The company has strategic collaborations with Sensorion and GN Hearing A/S to focus on improving hearing outcomes in patients with cochlear implants. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia.
Read More
Cochlear logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.90 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-2-94286555

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.48 billion
Cash FlowA$1.48 per share
Book ValueA$13.95 per share

Profitability

Miscellaneous

Employees3,500
Market Cap$10.53 billion
Next Earnings DateN/A
OptionableOptionable

Receive COH News and Ratings via Email

Sign-up to receive the latest news and ratings for COH and its competitors with MarketBeat's FREE daily newsletter.


Cochlear (ASX:COH) Frequently Asked Questions

How has Cochlear's stock been impacted by COVID-19 (Coronavirus)?

Cochlear's stock was trading at A$189.02 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, COH shares have decreased by 3.7% and is now trading at A$182.02. View which stocks have been mosted impacted by Coronavirus.

How were Cochlear's earnings last quarter?

Cochlear Limited (ASX:COH) released its earnings results on Tuesday, February, 19th. The company reported $2.15 earnings per share for the quarter, missing the Zacks' consensus estimate of $2.19 by $0.04. View Cochlear's earnings history.

How often does Cochlear pay dividends? What is the dividend yield for Cochlear?

Cochlear announced a Interim dividend on Wednesday, February 19th. Stockholders of record on Friday, April 17th will be given a dividend of 1.60 per share on Friday, April 17th. This represents a yield of 0.64%. The ex-dividend date is Tuesday, March 24th. This is an increase from Cochlear's previous Interim dividend of $1.55. View Cochlear's dividend history.

Has Cochlear been receiving favorable news coverage?

Press coverage about COH stock has been trending very negative recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cochlear earned a news impact score of -3.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutCochlear.

Who are some of Cochlear's key competitors?

What other stocks do shareholders of Cochlear own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cochlear investors own include iShares Core S&P 500 ETF (IVV), ResMed (RMD), CSL (CSL), Alumina (AWC), Nufarm (NUF), REA Group (REA), TPG Telecom (TPM), Janus Henderson Group (HGG), Mesoblast (MESO) and Omnicell (OMCL).

Who are Cochlear's key executives?

Cochlear's management team includes the following people:
  • Mr. Diggory William Howitt, CEO, MD, Pres & Exec. Director (Age 52)
  • Mr. Brent Andrew Cubis, Chief Financial Officer
  • Mr. Jan Janssen, Chief Technology Officer
  • Mr. Richard Brook, Pres of EMEA & Latin American Region
  • Mr. Anthony Manna, Pres of Americas Region

What is Cochlear's stock symbol?

Cochlear trades on the ASX under the ticker symbol "COH."

What is Cochlear's stock price today?

One share of COH stock can currently be purchased for approximately A$182.02.

How big of a company is Cochlear?

Cochlear has a market capitalization of $10.53 billion and generates $1.48 billion in revenue each year. Cochlear employs 3,500 workers across the globe. View additional information about Cochlear.

What is Cochlear's official website?

The official website for Cochlear is http://www.cochlear.com/.

How can I contact Cochlear?

Cochlear's mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company can be reached via phone at +61-2-94286555.

This page was last updated on 4/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel